nMRCGP exam update - Evidence for aspirin use
Contributed by Dr Louise Newson, a GP in the West Midlands. Read more
The latest GMS prevalence data shows that while the overall prevalence of cancer as recorded on quality registers in the UK has increased, from an average of 0.52 per cent in 2004/5 to 0.78 per cent for 2005/6, the pattern of cancer prevalence remains unchanged.
Major cities such as London, Manchester, Glasgow and Birmingham were found to have low levels of cancer prevalence, with the lowest prevalence in the UK found in north-east London.
Ruth Yates, head of statistical information at Cancer Research UK, said that fewer cases of cancer are identified in the major cities because of the younger population found in cities. Young people are moving away from rural areas and are drawn to major urban areas, she said.
‘As cancer risk increases with increasing age, a population with a higher proportion of older people will have a higher incidence and prevalence of cancer.’
This is the most likely explanation for lower prevalence in urban areas, she said.
The most prevalent cancer areas in the UK were found throughout Wales (excluding Cardiff, Swansea and Newport), the Scottish borders and in Dorset and Somerset. These areas are popular retirement spots and contain a high proportion of elderly people.
But Somerset GP Dr Greg Tanner, Macmillan GP adviser and cancer lead in the Somerset area, said he had not noticed a larger number of cancer patients at his practice.
‘Maybe the incidence of cancer is higher in south-west England because of the sunnier climate causing melanomas,’ he said.
However, the data needs to be broken down into age and cancer type before any conclusions can be drawn, said Dr Tanner.
Ms Yates said that if the map were to take into account individual cancers, the prevalence of lung cancer would relate strongly to patterns of smoking. Therefore, Scotland and north east England would have the highest prevalence of lung cancer.
‘Conversely, prevalence of breast and prostate cancer would be higher in the more affluent areas, such as the south east of England,’ she said.
‘The pattern for bowel cancer would be unclear as there appears to be no geographical variation.’
Contributed by Dr Louise Newson, a GP in the West Midlands. Read more
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more
Comments
Only registered users may comment. Log in now or register for a free account.